2017
DOI: 10.1016/j.rmed.2017.08.007
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: Imaging modalities are valuable tools for the characterization of skeletal muscle dysfunction in chronic lung disease in clinical and research settings. The use of muscle imaging as a prognostic marker is promising and requires further study.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(11 citation statements)
references
References 97 publications
0
11
0
Order By: Relevance
“…Several recent systematic reviews and meta-analyses impressively demonstrated that muscle imaging by quantitative CT plays an important role in a large variety of diseases affecting organs such as the lung [71] , liver [72] , [73] , or abdomen [74] , [75] . Further systematic reviews were dedicated to muscle characteristics in cerebral palsy [76] , vascular claudication [77] , low back pain [78] , and muscle fatigue in old age [79] .…”
Section: Applications Of Quantitative Muscle Imaging By Ctmentioning
confidence: 99%
“…Several recent systematic reviews and meta-analyses impressively demonstrated that muscle imaging by quantitative CT plays an important role in a large variety of diseases affecting organs such as the lung [71] , liver [72] , [73] , or abdomen [74] , [75] . Further systematic reviews were dedicated to muscle characteristics in cerebral palsy [76] , vascular claudication [77] , low back pain [78] , and muscle fatigue in old age [79] .…”
Section: Applications Of Quantitative Muscle Imaging By Ctmentioning
confidence: 99%
“…Poor status of n-3 PUFA has been reported in many chronic diseases where low mass muscle mass has been reported separately including Rheumatoid Arthritis (RA) (17), Chronic Obstructive Pulmonary Disease (COPD) (18)(19)(20), liver disease (Non Alcoholic Fatty Liver Disease and cirrhosis) (21,22); cancer (23)(24)(25); diabetes (17,26,27), Chronic Kidney Disease (28), Heart Disease (29) and Alzheimer's disease (30)(31)(32). The two features of poor n-3 PUFA status and low muscle mass may be related events rather than isolated events (23).…”
Section: Status Of N-3 Fatty Acids and Low Muscle Mass Are Generally Independently Evaluated In Chronic Diseasesmentioning
confidence: 99%
“…Arguably, imaging by MRI or CT is the current gold-standard approach for assessing muscle mass (Engstrom et al, 1991;Morse et al, 2007;Clark et al, 2018). Similarly, MRI and CT can be used to assess fat infiltration of muscle as an index of muscle compositional quality (Rozenberg et al, 2017;Engelke et al, 2018;Correa-de-Araujo et al, 2020). While MRI and CT are highly accurate and repeatable, they are expensive, housed in a separate facility, and require extensive post-processing that dramatically limits their clinical utility.…”
Section: Introductionmentioning
confidence: 99%